- Home
- ACTG vs EBS Comparison
ACTG vs EBS Comparison
Compare ACTG & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACTG | EBS |
|---|---|---|
| Founded | 1993 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.9M | 409.5M |
| IPO Year | 1995 | 2006 |
Fundamental Metrics
Financial Performance| Metric | ACTG | EBS |
|---|---|---|
| Price | $4.81 | $8.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.00 | ★ $12.00 |
| AVG Volume (30 Days) | 437.6K | ★ 906.1K |
| Earning Date | 03-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 161.11 | 125.83 |
| EPS | 0.22 | ★ 0.93 |
| Revenue | $12,004,000.00 | ★ $742,900,000.00 |
| Revenue This Year | N/A | $1.29 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $22.00 | ★ $8.66 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.70 | $4.02 |
| 52 Week High | $5.21 | $14.06 |
Technical Indicators
Market Signals| Indicator | ACTG | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 58.84 | 40.86 |
| Support Level | $3.54 | $7.72 |
| Resistance Level | $5.21 | $9.28 |
| Average True Range (ATR) | 0.19 | 0.29 |
| MACD | -0.03 | 0.11 |
| Stochastic Oscillator | 29.52 | 68.33 |
Price Performance
Historical ComparisonAbout ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.